Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 12851 - 12875 of 14359 in total
Rovaleucel is an EBV-specific autologous T-cell therapy under investigation for the treatment of EBV-positive cancers.
Investigational
Metelimumab (CAT-192) is a monoclonal antibody targeted against transforming growth factor (TGF) beta-1.
Investigational
Investigational
Olezarsen is an antisense oligonucleotide targeting messenger RNA for apolipoprotein C-III (APOC3).
Investigational
Asimadoline is a proprietary small molecule therapeutic, originally discovered by Merck KGaA of Darmstadt, Germany. Asimadoline was originally developed to treat peripheral pain such as arthritis. Asimadoline is an orally administered agent that acts as a kappa opioid receptor agonist. It has shown encouraging clinical efficacy for the treatment of...
Investigational
Matched Description: … has shown encouraging clinical efficacy for the treatment of IBS in a barostat study in IBS patients and
Experimental
Pumosetrag has been used in trials studying Gastroesophageal Reflux Disease.
Investigational
alpha-methylthiofentanyl is an opioid analgesic that is an analog of fentanyl.
Illicit
Displaying drugs 12851 - 12875 of 14359 in total